Recent News

The 2023 GSK Chairman’s Prize recognizes Chi Nguyen for research on gut health.

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

New MSK research finds a potential target against neuroendocrine transformation in lung and prostate cancers; discovers new clues about why donor T cells attack certain tissues in graft-versus-host disease; sheds light on why T cells let go of their prey; and uses CRISPR interference and dynamic cell-state transitions to discover enhancers that affect early human development.

New MSK research identified a way to reduce toxicity in CAR T cell therapy; discovered a division of labor in DNA repair that suggests a possible therapeutic strategy for certain cancers; developed a new method to enable imaging of two PET tracers simultaneously; found biomarkers that could help predict outcomes in HER2-positive metastatic esophagogastric cancer; and made progress toward improving options for patients with early-stage, potentially indolent cancers.

New MSK research discovered ferroptosis regulators that suggest therapeutic opportunities against hormone receptor-positive cancers; examined how tumor-associated macrophages might be turned against cancer; acquired new insights into joint inflammation in rheumatoid arthritis; developed a systems-level platform called epichaperomics to map changes in interactors among thousands of proteins involved in cancer-related processes; and investigated how artificial intelligence could help diagnose an invasive form of breast cancer.

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

This story answers common questions about how your gut microbiota impacts your health, how to protect it, and the impact it has on diseases like cancer.

MSK-led research found an unexpected link between chromosomal instability and epigenetic alternations, both of which are hallmarks of cancer — especially advanced, drug-resistant cancers.

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

The Marie-Josée Kravis Center for Cancer Immunobiology (CCI), made possible by a generous $40 million gift from Henry R. Kravis to honor the visionary leadership of his wife, Marie-Josée Kravis, will establish a strategic research infrastructure that will seamlessly unite MSK scientists and physicians to further accelerate immunotherapy treatments for people with cancer.